Cite

HARVARD Citation

    Greene, S. et al. (2021). Long-Term Nonclinical Pulmonary Safety Assessment of Afrezza, a Novel Insulin Inhalation Powder. Toxicologic pathology. pp. 334-348. [Online]. 
  
Back to record